Anti-TB Drugs: And Then There Were None

+ See all authors and affiliations

Science  18 Jul 2008:
Vol. 321, Issue 5887, pp. 364
DOI: 10.1126/science.321.5887.364

You are currently viewing the summary.

View Full Text


Two crucial antituberculosis drugs, capreomycin and cycloserine, are valued today precisely because they didn't seem valuable a short time ago.